Science Explorer Back to mapMap
Institution · Novo Nordisk (Denmark)

Most cited papers from Novo Nordisk (Denmark)

What are the most cited papers from Novo Nordisk (Denmark)?

The most cited paper from Novo Nordisk (Denmark) is "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes" (Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al., 2016), with 7,629 citations. Next come "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes" (6,902) and "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (5,049).

Showing 50 of 60 papers. Every paper with more than 903 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine Open access 13 Jun 2016 7,629
2 Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Steven P. Marso, Stephen Charles Bain, Agostino Consoli et al. · New England Journal of Medicine Open access 16 Sep 2016 6,902
3 Once-Weekly Semaglutide in Adults with Overweight or Obesity John P.H. Wilding, Rachel Louise Batterham, Salvatore Calanna et al. · New England Journal of Medicine Open access 10 Feb 2021 5,049
4 The complete genome sequence of the Gram-positive bacterium Bacillus subtilis Frank Kunst et al. · Nature Open access151 authors Nov 1997 3,720
5 Epigenetic differences arise during the lifetime of monozygotic twins Mario Fernández Fraga et al. · Proceedings of the National Academy of Sciences Open access 11 Jul 2005 3,643
6 A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management Xavier Pi-Sunyer, Arne Vernon Astrup, Ken Fujioka et al. · New England Journal of Medicine Open access Jul 2015 2,708
7 Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 Thomas Ray Einarson, Annabel Acs, Craig Ludwig et al. · Cardiovascular Diabetology ReviewOpen access 8 Jun 2018 2,405
8 High-energy-physics event generation with Pythia 6.1 Torbjörn Sjöstrand, P. Edén, Christer Friberg et al. · Computer Physics Communications Open access Apr 2001 2,060
9 Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark et al. · New England Journal of Medicine Open access 11 Jun 2019 2,006
10 A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis Philip Noel Newsome, Kristine Buchholtz, Kenneth J. Cusi et al. · New England Journal of Medicine Open access 13 Nov 2020 2,006
11 Time-dependent transport in interacting and noninteracting resonant-tunneling systems Antti‐Pekka Jauho, Ned S. Wingreen, Yigal Meir · Physical review. B, Condensed matter Open access 15 Aug 1994 1,945
12 Quark confinement and topology of gauge theories Alexander M. Polyakov · Nuclear Physics B Mar 1977 1,852
13 Glucagon-like peptide 1 (GLP-1) Timo D. Müller et al. · Molecular Metabolism Open access 30 Sep 2019 1,836
14 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Vlado Perkovic, Katherine R. Tuttle, Peter R Rossing et al. · New England Journal of Medicine 24 May 2024 1,815
15 Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus Claus Morten Larsen, Mirjam V. Faulenbach, Allan Arthur Vaag et al. · New England Journal of Medicine Open access 11 Apr 2007 1,813
16 Neural Network Ensembles, Cross Validation, and Active Learning Anders Krogh, Jesper Vedelsby 1994 1,802
17 Plasma proteomic associations with genetics and health in the UK Biobank Benjamin B. Sun et al. · Nature Open access 4 Oct 2023 1,716
18 Astrophysical magnetic fields and nonlinear dynamo theory Axel Brandenburg, Kandaswamy Subramanian · Physics Reports Open access 7 Sep 2005 1,663
19 Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) John B. Buse, Julio Rosenstock, Giorgio Sesti et al. · The Lancet 9 Jun 2009 1,505
20 Conformal algebra and multipoint correlation functions in 2D statistical models Vl.S. Dotsenko, Vladimir Aleksandrovich Fateev · Nuclear Physics B Oct 1984 1,425
21 Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0 Laurent Heirendt et al. · Nature Protocols Open access 20 Feb 2019 1,399
22 Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Melanie J. Davies, Louise Færch, Ole Kleist Jeppesen et al. · The Lancet Open access Mar 2021 1,384
23 Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity Domenica Rubino et al. · JAMA Open access 23 Mar 2021 1,377
24 Quantum field-theoretical methods in transport theory of metals J. Rammer, H. Smith · Reviews of Modern Physics Apr 1986 1,369
25 Deciphering cell–cell interactions and communication from gene expression Erick Armingol, Adam Officer, Olivier Harismendy et al. · Nature Reviews Genetics ReviewOpen access 9 Nov 2020 1,367
26 NASH limits anti-tumour surveillance in immunotherapy-treated HCC Dominik Reinhard Pfister et al. · Nature Open access110 authors 24 Mar 2021 1,304
27 A Simple Weight Decay Can Improve Generalization Anders Krogh, John Hertz 1992 1,293
28 Hypothalamic CART is a new anorectic peptide regulated by leptin Peter Lommer Kristensen, Martin E. Judge, Lars Thim et al. · Nature May 1998 1,293
29 The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review Susanne Fredenberg, Marie Wahlgren, Mats Reslow et al. · International Journal of Pharmaceutics 27 May 2011 1,283
30 Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine Open access 14 May 2008 1,265
31 A serine protease triad forms the catalytic centre of a triacylglycerol lipase Leo Brady, Andrzej Marek Brzozowski, Zygmunt S. Derewenda et al. · Nature Feb 1990 1,215
32 Effect of Environmental Factors on the Kinetics of Insulin Fibril Formation: Elucidation of the Molecular Mechanism Liza Nielsen, Ritu Khurana, Alisa C. Coats et al. · Biochemistry 24 Apr 2001 1,197
33 Radiative energy loss and p⊥-broadening of high energy partons in nuclei R. Baier, Yuri L. Dokshitzer, A.H. Mueller et al. · Nuclear Physics B Open access 1997 1,184
34 Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine Open access 23 Feb 2005 1,172
35 Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode et al. · JAMA Open access 18 Aug 2015 1,172
36 Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study Arne Vernon Astrup, Stephan Rössner, Luc Van Gaal et al. · The Lancet 24 Oct 2009 1,169
37 Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes Michael Albrecht Nauck, Anders H. Frid, Kjeld Hermansen et al. · Diabetes Care Open access 17 Oct 2008 1,128
38 Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide Jesper F. Lau, Paw Bloch, Lauge Schäffer et al. · Journal of Medicinal Chemistry Open access 26 Aug 2015 1,092
39 Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity Thomas A. Wadden, Timothy Silleck Bailey, Liana K. Billings et al. · JAMA Open access 24 Feb 2021 1,078
40 New Unstable Variants of Green Fluorescent Protein for Studies of Transient Gene Expression in Bacteria Jens Bo Andersen, Claus Sternberg, Lars Kongsbak Poulsen et al. · Applied and Environmental Microbiology Open access Jun 1998 1,078
41 Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension John P.H. Wilding, Rachel Louise Batterham, Melanie J. Davies et al. · Diabetes Obesity and Metabolism Open access 19 Apr 2022 1,066
42 Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial Alan J. Garber, Robert R. Henry, Robert E. Ratner et al. · The Lancet 25 Sep 2008 1,058
43 BiGG Models: A platform for integrating, standardizing and sharing genome-scale models Zachary A. King, Justin S. Lu, Andreas Dräger et al. · Nucleic Acids Research Open access 17 Oct 2015 1,053
44 Exchange-correlation energy of a metallic surface: Wave-vector analysis David C. Langreth, John P. Perdew · Physical review. B, Solid state 15 Mar 1977 1,052
45 Bound state properties of Borromean halo nuclei: 6He and 11Li Maxim Vitalievich Zhukov, B. V. Danilin, Daniil V. Fedorov et al. · Physics Reports Aug 1993 1,033
46 FDA-approved small-molecule kinase inhibitors Peng Wu, Thomas E. Nielsen, Mads H. Clausen · Trends in Pharmacological Sciences ReviewOpen access 12 May 2015 1,031
47 Radiative energy loss of high energy quarks and gluons in a finite-volume quark-gluon plasma R. Baier, Yuri L. Dokshitzer, Alfred H. Mueller et al. · Nuclear Physics B Open access 1997 1,025
48 GALACTIC MAGNETISM: Recent Developments and Perspectives Rainer Beck, Axel Brandenburg, David L. Moss et al. · Annual Review of Astronomy and Astrophysics Review Sep 1996 1,014
49 Interatomic interactions in the effective-medium theory Karsten W. Jacobsen, Jens K. Nørskov, Martti J. Puska · Physical review. B, Condensed matter Open access 15 May 1987 985
50 Qualitative research and content validity: developing best practices based on science and experience Meryl I. Brod, Laura E. Tesler, Torsten L. Christensen · Quality of Life Research 26 Sep 2009 970

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.